Interpreting low testosterone with equivocal repeat values
A 38-year-old man is referred for fatigue and reduced libido. A morning (08:10) total testosterone is 9.1 nmol/L (reference ~10–30 nmol/L) and SHBG is 52 nmol/L (upper-normal). LH is 3.8 IU/L and FSH is 4.1 IU/L. A repeat morning sample two weeks later gives total testosterone 10.4 nmol/L. He has a BMI of 33, reports poor sleep, and takes no medications. The laboratory also has a calculated free testosterone available from total testosterone and SHBG. The referring clinician asks whether this represents hypogonadism requiring treatment.
1. How should the laboratory interpret the two total testosterone values and the calculated free testosterone in this man?
Read the worked answer
Two values should be interpreted together, not as a single threshold decision. The first (9.1 nmol/L) is below the reference range; the second (10.4 nmol/L) is at the lower margin. Because total testosterone fluctuates and single low values are common, the laboratory should report both with collection times and note that the diagnosis of biochemical hypogonadism generally requires consistently low morning values on more than one occasion, not a single result. The calculated free testosterone matters here: with an SHBG of 52 nmol/L (upper-normal), a substantial fraction of total testosterone is bound, so free testosterone will be lower than the total suggests. The laboratory should report the calculated free value with the formula and inputs stated, and flag that low free testosterone with upper-normal SHBG is a pattern consistent with reduced free hormone availability rather than a laboratory error.
2. What endocrine pattern does the LH/FSH result suggest, and what confounders should be flagged before any treatment decision?
Read the worked answer
LH 3.8 and FSH 4.1 IU/L are inappropriately low-normal for a man with low testosterone - the expected response to low testosterone would be elevated gonadotropins. This points toward a secondary (central) pattern rather than primary testicular failure, though the values are not frankly suppressed and a single set is not diagnostic. The laboratory should flag that this pattern warrants clinical correlation (e.g., assessment for pituitary causes, sleep apnea, obesity-related suppression, or medication/illicit substance effects) rather than proceeding directly to testosterone therapy, which could further suppress an already central axis. Confounders to flag: obesity (BMI 33) and poor sleep can lower morning testosterone; the sample timing should be confirmed as true morning; and the borderline repeat value means the biochemical picture is not yet established. The laboratory's role is to report accurately, state reference ranges and timing, and recommend repeat morning testing with SHBG and calculated free testosterone before any treatment decision.